🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Maria Chaparro Uma Mahadevan GETECCU Mette Julsgaard Spectacular presentation by Mette Julsgaard Very clear presentation representing an outstanding panel

Safety of lactation in women patients with #IBD and vaccination of infants born to mothers with IBD So much data to process throughout all this session with great content and summaries Fantastic Mette Julsgaard at Digestive Disease Week #DDW2024

Thank you Fernando Gomollón. Maria Chaparro has done a splendid job as lead in the “vaccine” group. She was greatly missed at Digestive Disease Week & the PIANO Global Consensus summit

Thank you SO much to Uma Mahadevan, Millie Long, Joana Torres, Mette Julsgaard, Cynthia Seow, and Siew Ng for the incredible presentation and synthesis of evidence! And of course, thanks to the entire Global Consensus team including patient advocate Natalie Hayden 💜

D'Haens - Miri not inferior to Ustk in mod-severe #crohnsdisease, in treat-through RCT with some separation btw Miri & Ustk in secondary endpoints. Different study design and patient pop from SEQUENCE-CD #DDW2024 #IBD

Let’s all give a shout out to Beatriz Gros for her phenomenal work summarizing Digestive Disease Week so beautifully. Perfect photos. Perfect summary. Muchissimas Gracias Bea!

Thank you Beatriz Gros for highlighting our 🇪🇺 #ECCO & #EMCG multi-center study. Bram Verstockt Y-ECCO

Catching up with some of the legends who worked so hard to put together #GRADE consensus. Special kudos to Uma Mahadevan for her leadership with PIANO. #DDW2024 Mette Julsgaard Cynthia Seow Emma Flanagan

Patient perspectives on prediction & prevention of #IBD is of great importance. Thank you Joana Torres & team for including us at Department of Hepatology and Gastroenterology, AUH 🇩🇰Aarhus Uni.hospital Aarhus University

Mette Julsgaard Aline Charabaty, MD, FACG, AGAF Puja Mehta 🧩 🌻 Beatriz Gros Jonny Blackwell Fabi An E. Puentes M. #MondayNightIBD AbbVie JanssenUS ignacio catalan Ashkan Rezazadeh MD Angus Worthing MD Ethan Craig B. Evana Ghassemi, PHARMD, BCACP, BCPS David Choi, PharmD Jason Schairer Sophie Restellini Joseph Sleiman, MD Miquel Marquès Manuel Braga Neto MD, PhD LT 👩🏼‍⚕️ 🥥🌴 Rafeeq Piotr Eder Richard Hansen John Ding MD PhD Anjan Dhar Natalia Queiroz Robert Battat MD DraVivianaParra Abel Novillo Virginia Solitano Lucía Madero Raja Affendi MB BCh, MMed.Sc,MD, FRCP, AGAF, MBA FMsro Patriciakaazan Pauli Maria Manuela Estevinho Munique Kurtz de Mello Vishal Sharma Uma Mahadevan Thank you Mette for stating this with so clear and solid arguments. Greatly needed to avoid some doubts and avoiding unnecessary (sometimes severe) relapses. 👏👏👏

Join this important multidisciplinary meeting hosted by U.S. FDA on Evaluating Immunosuppressive Effects of In Utero Exposure to Drug and Biologic Products. Hear experts discuss available data, key data gaps and best steps forward. Free Registration --> lu.ma/5vdmbibm

SAFETY IN PREGNANCY🚨largest cohort study + systematic review on 💊#Allopurinol + #thiopurine for #IBD during 🤰🏼. Great 🇳🇱🇩🇰 collaboration. Thank you #Nanne_K_de_Boer & #Femke_Crouwel Vrije Universiteit Amsterdam for including me. doi.org/10.1111/apt.18… roypounder.apt Department of Hepatology and Gastroenterology, AUH HealthAU Aarhus Uni.hospital

Great U.S. FDA workshop on evaluating immunosuppressive effects of in utero exposure to drug and biologic products. I had the opportunity to present PIANO data and learn from experts across disciplines. what I learned 1/4:

Agree Aline Charabaty, MD, FACG, AGAF biologics should be 1st choice, but 🌎 it isn’t accessible to all. Ralley Prentice🇦🇺 showed AZA shunting in 24%🤰🏼➡️⬆️MMP/6-TGN➡️⬆️intrahepatic cholestasis of🤰🏼. Solution: Split AZA dosing OR combi with ALLO. Our ALLO data adds to safety in🤰🏼❗️shared decision with pt.!

🔥NEW DATA! Largest cohort to date on #upadacitinib & 🤰🏼. No adverse signals. Reassuring data for women who have no other option than continue in pregnancy in order to ensure remission. IBDMoms AbbVie AbbVie Danmark

Risankizumab for Ulcerative Colitis jamanetwork.com/journals/jama/… JAMA Remo Panaccione, MD, FRCPC Jean-Frederic Colombel

Proud to share this new article📣 We studied impact of parents’ IBD status during pregnancy on offspring’s IBD risk👶 Risk increased when either parent has IBD before childbirth. This would not have been possible without amazing co-authors, role models and supervisors🙏

🌟 Watch Rising Stars shine at UEG Week! 🌟 Don't miss the talk by our Rising Star @julsgaardmette at #UEGWeek 2024: 'Fetal exposure to maternal medical treatment for IBD and its impact on pregnancy outcome and child development'. 🔗 bit.ly/3SLNjdp #myUEGcommunity

Maternal & paternal IBD diagnosis before parenthood ➡️⬆️ risk of IBD in the offspring. Factors other than exposure in 🤰🏼play a role in risk of #IBD in offspring. Outstanding work Linea Bonfils Great 🇩🇰🇺🇸🇵🇹collaboration. Department of Hepatology and Gastroenterology, AUH Aarhus Uni.hospital Aarhus University PREDICT IBD Gut Journal IBDMoms

A new important study by my great colleague Anne Grosen. #tofacitinib does not influence sperm quality in humans Department of Hepatology and Gastroenterology, AUH Aarhus Uni.hospital IBDJournal & CC360